MALE INFLAMMATORY BREAST CANCER-AN ANALYSIS

Yasir Ahmed  Alsalamah; Sajad Ahmad Salati; Lamees Sulaiman AlSulaim

doi:10.5937/sanamed0-48924

Yasir Ahmed Alsalamah Qassim University, College of Medicine, Department of Surgery, Unaizah, Saudi Arabia
Sajad Ahmad Salati Qassim University, College of Medicine, Department of Surgery, Unaizah, Saudi Arabia
Lamees Sulaiman AlSulaim Qassim University, College of Medicine, Department of Surgery, Unaizah, Saudi Arabia

DOI: https://doi.org/10.5937/sanamed0-48924

Keywords: inflammatory breast cancer, erythema, metastasis, mastectomy, chemotherapy, hormone therapy, radiation therapy, prognosis

Abstract

Inflammatory breast cancer in males is an uncommon but extremely aggressive form of the disease. It is often misdiagnosed as a benign skin disease since it manifests as erythema along the chest wall. The management guidelines are not specific, and treatment is based on the experiences of female cancer patients. Since there is limited information available about this illness, this review aims to fill that gap by conducting a thorough analysis of case reports published in peer-reviewed journals since 2000.

Author Biographies

Yasir Ahmed Alsalamah , Qassim University, College of Medicine, Department of Surgery, Unaizah, Saudi Arabia

ORCID: 0009-0004-8575-0974

Sajad Ahmad Salati, Qassim University, College of Medicine, Department of Surgery, Unaizah, Saudi Arabia

ORCID: 0000-0003-2998-7542

Lamees Sulaiman AlSulaim , Qassim University, College of Medicine, Department of Surgery, Unaizah, Saudi Arabia

ORCID:0000-0002-5785-8468

References

Rosenbluth JM, Overmoyer BA. Inflammatory breast cancer: a separate entity. Curr Oncol Rep. 2019;21(10):86. doi: 10.1007/s11912-019-0842-y.

Menta A, Fouad TM, Lucci A, Le-Petross H, Stauder MC, Woodward WA, et al. Inflammatory breast cancer: What to know about this unique, aggressive breast cancer. Surg Clin North Am. 2018;98(4):787-800. doi: 10.1016/j.suc.2018.03.009.

Newman AB, Lynce F. Tailoring treatment for patients with inflammatory breast cancer. Curr Treat Options Oncol. 2023;24(6):580-93. doi: 10.1007/s11864-023-01077-0.

Hester RH, Hortobagyi GN, Lim B. Inflammatory breast cancer: early recognition and diagnosis is critical. Am J Obstet Gynecol. 2021;225(4):392-6. doi: 10.1016/j.ajog.2021.04.217.

Yalaza M, İnan A, Bozer M. Male breast cancer. J Breast Health. 2016;12(1):1-8. doi: 10.5152/tjbh.2015.2711.

Moayeri H, Rezagholi P. Inflammatory breast cancer in a 53‑year‑old man. Adv Biomed Res 2022;11:9. doi: 10.4103/abr.abr_117_21.

Tanhueco A, Youssef MMG. Inflammatory breast cancer in men: A rare clinical case report and a literature review. Int J Surg Case Rep. 2021;80:105696. doi: 10.1016/j.ijscr.2021.105696.

Tashima Y, Kusanagi K, Takeda Y, Yoshimatsu K, Ishida T, Shinohara S, et al. A case report of luminal A male inflammatory breast cancer that was difficult to treat because of Trousseau syndrome. J UOEH. 2019;41(2):211-6. [Article in Japanese]. doi: 10.7888/juoeh.41.211.

Hyakudomi M, Inao T, Minari Y, Itakaru M, Maruyama R, Tagima Y. A case of male inflammatory breast cancer. Int Canc Conf J. 2013;2:183–7. doi: 10.1007/s13691-013-0087-9.

Loewen AH, Schilling SD, Milroy M, Villanueva ML. Case Report: Hormone Receptor Positive, HER2/neu negative inflammatory breast cancer in a male patient. SD Med. 2015;68(10):435-7, 439-40.

Morita Y, Syoji T, Goto H, Nakajima T, Hukasawa T, Taniwaka K. A case report of male inflammatory breast cancer. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2005;66(1):36–40.

Choueiri MB, Otrock ZK, Tawil AN, El-Hajj II, El Saghir NS. Inflammatory breast cancer in a male. N Z Med J. 2005;118(1218):U1566.

Spigel JJ, Evans WP, Grant MD, Langer TG, Krakos PA, Wise DK. Male inflammatory breast cancer. Clin Breast Cancer. 2001;2(2):153-5. doi: 10.3816/CBC.2001.n.020.

Abner A, Kaufman M, Pories S, Gauvin G. Unusual presentations of malignancy. Case 1. Male inflammatory (?) breast cancer. J Clin Oncol. 2001;19(13):3288-9. doi: 10.1200/JCO.2001.19.13.3288.

Ha KY, Glass SB, Laurie L. Inflammatory breast carcinoma. Proc (Bayl Univ Med Cent). 2013;26(2):149-51. doi: 10.1080/08998280.2013.11928940.

Taylor GW, Meltzer A. „Inflammatory carcinoma” of the breast. Am. J. Cancer 1938; 33:33–49.

Aysola K, Desai A, Welch C, Xu J, Qin Y, Reddy V, et al. Triple Negative Breast Cancer - an overview. Hereditary Genet. 2013;2013(Suppl 2):001. doi: 10.4172/2161-1041.S2-001.

Dawood S, Ueno NT, Cristofanilli M. The medical treatment of inflammatory breast cancer. Semin Oncol. 2008;35(1):64-71. doi: 10.1053/j.seminoncol.2007.11.012.

Johnson KC, Grimm M, Sukumar J, Schnell PM, Park KU, Stover DG, et al. Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls. Breast. 2023 Dec;72:103591. doi: 10.1016/j.breast.2023.103591.

Sabih QA, Young J, Takabe K. Management of male breast cancer: The journey so far and future directions. World J Oncol. 2021;12(6):206-13. doi: 10.14740/wjon1418.